- Home
- MIND vs GOSS Comparison
MIND vs GOSS Comparison
Compare MIND & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MIND | GOSS |
|---|---|---|
| Founded | 1987 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.4M | 88.6M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | MIND | GOSS |
|---|---|---|
| Price | $6.66 | $0.20 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $4.19 |
| AVG Volume (30 Days) | 145.3K | ★ 4.2M |
| Earning Date | 04-15-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $48,471,000.00 |
| Revenue This Year | $23.31 | N/A |
| Revenue Next Year | $1.01 | $201.64 |
| P/E Ratio | $22.27 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.51 | $0.31 |
| 52 Week High | $14.50 | $3.87 |
Technical Indicators
Market Signals| Indicator | MIND | GOSS |
|---|---|---|
| Relative Strength Index (RSI) | 45.53 | 21.46 |
| Support Level | $5.92 | N/A |
| Resistance Level | $6.76 | $0.47 |
| Average True Range (ATR) | 0.35 | 0.03 |
| MACD | 0.09 | 0.00 |
| Stochastic Oscillator | 46.79 | 15.46 |
Price Performance
Historical ComparisonAbout MIND MIND Technology Inc. (DE)
MIND Technology Inc provides technology and solutions for exploration, survey, and defense applications in oceanographic, hydrographic, defense, seismic, and security industries. The company operates in segments namely, Seamap Marine Products and Klein Marine Products helps manufacture and sell specialized, high-performance sonar and seismic equipment. The company generates more revenue from Seamap Marine Products. The company's geographical segments include the United States; China, Norway; Turkey; Singapore; and Canada & Other.
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).